-
Oct 7, 2024 | 
onlinelibrary.wiley.com | Thomas Naduvilath |Xiangui He |Kathryn J. Saunders |Pelsin Demir
Axial elongation and myopia progression vary by age and region/ethnicity, where East Asian eyes have higher age-specific progression compared with European eyes. Regional/ethnic differences are age-specific, where larger differences are observed in younger ages. Regional/ethnic differences in axial elongation are observed in both myopic and non-myopic eyes, but are greater in myopic eyes.
-
Jul 2, 2024 | 
onlinelibrary.wiley.com | Pelsin Demir |Karthikeyan Siva Baskaran |Pedro Ramos |Thomas Naduvilath
The 2-year incidence of myopia among Swedish schoolchildren was low. The risk factors for refractive error changes were parental myopia and being already a myope at the start of the study. A new hypothesis is raised that low educational pressure in early childhood might protect Swedish children from abnormal emmetropisation leading to myopia. INTRODUCTION The prevalence of myopia in Scandinavia is lower than in other parts of the world.
-
Feb 1, 2024 | 
reviewofmm.com | Vittorio Mena |Thomas Naduvilath |Huy Tran |Huy Trần
February 1, 2024By Vittorio Mena, OD, MSFollowing the school nurse’s evaluation, it is up to the parents to find an eye care practitioner to get a comprehensive eye examination for their child. The only problem is that statistics show that 67% of students who fail a vision screening do not go and get an eye exam. Of our five senses, the last one anybody would want to lose is their vision. Ironically, though, it tends to be the last thing people think about, especially regarding children.
-
Jan 26, 2024 | 
reviewofmm.com | Thomas Naduvilath |Huy Tran |Huy Trần |Thi D. Duong
January 26, 2024MISSISSAUGA, Ontario, Canada — HOYA Vision Care is releasing a new Canadian public awareness campaign geared towards highlighting the benefits of MiYOSMART spectacle lenses for children with myopia. The campaign will drive awareness about the short- and long-term impacts of myopia progression among children.
-
Jan 26, 2024 | 
reviewofmm.com | Thomas Naduvilath |Huy Tran |Huy Trần |Thi D. Duong
January 25, 2024PRINCETON, N.J. — Hoot Myopia Care has released a new feature for ECPs that will help automate the process of administering pediatric referrals for myopia management. The program, Hoot Referrals, will work to assist optometrists specializing in myopia to increase referrals from pediatricians.
-
Jan 25, 2024 | 
reviewofmm.com | Thomas Naduvilath |Huy Tran |Huy Trần |Thi D. Duong
January 25, 2024ST. LOUIS — The World Council of Optometry (WCO) will be hosting “Myopia Management: From Theory to Practice,” its first Latin America-based virtual event, on February 20, 22, 27, and 29, 2024. Now, the organization has announced the speakers for the event. Speakers include:Sandra S.
-
Jan 24, 2024 | 
reviewofmm.com | Thomas Naduvilath |Huy Tran |Huy Trần |Thi D. Duong
January 24, 2024DUBLIN, Ireland — Ocumetra has released new updates to its mEYE Guide and mEYE Gauge software for ECPs. The revamped platform introduces a sleek design while maintaining a user-friendly interface. Notably, data entry for both mEYE Guide and mEYE Gauge has been streamlined into a single form, optimizing chair time efficiency in practice. Among the new features is axial length analysis using either estimated or measured axial length data.
-
Jan 22, 2024 | 
reviewofmm.com | Thomas Naduvilath |Huy Tran |Huy Trần |Thi D. Duong
January 22, 2024LAS VEGAS — Visioneering Technologies Inc. (VTI) is sharing results from its ongoing PROTECT Trial (PROgressive Myopia Treatment Evaluation for NaturalVue Multifocal Contact Lens Trial). The PROTECT Trial is a multi-national, double-masked, randomized controlled trial designed to demonstrate the safety and effectiveness of NaturalVue Multifocal 1 Day contact lenses (NVMF) for myopia progression control in children.
-
Jan 19, 2024 | 
reviewofmm.com | Thomas Naduvilath |Huy Tran |Huy Trần |Thi D. Duong
January 19, 2024SAN DIEGO — Sydnexis announced that Erin Horn has been named the Vice President, Head of Market Access at the company. With a strong and diverse track record of commercial success in traditional and specialty ophthalmic pharmaceuticals, she will provide her market access, launch expertise, and commercial leadership to Sydnexis’ ongoing expansion and growth. Erin will lead Sydnexis’ market access, pricing, contracting, and go-to-market strategies.
-
Jan 18, 2024 | 
reviewofmm.com | Thomas Naduvilath |Kristen Dalli
January 18, 2024NEW YORK — Eyenovia has regained the rights to MicroPine, an investigational eight microliter ophthalmic spray of atropine delivered by Eyenovia’s proprietary Optejet device, in the United States and Canada. MicroPine is being evaluated as a potential treatment for pediatric progressive myopia.
